Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Clin Transl Oncol

Search In Journal Title:

Abbravation: Clinical and Translational Oncology

Search In Journal Abbravation:

Publisher

Springer International Publishing

Search In Publisher:

DOI

10.1007/bf00228909

Search In DOI:

ISSN

1699-3055

Search In ISSN:
Search In Title Of Papers:

Retroperitoneal lymph node dissection an update i

Authors: K Yadav
Publish Date: 2017/02/01
Volume: 19, Issue: 7, Pages: 793-798
PDF Link

Abstract

Management of testicular cancer has evolved through many breakthroughs The decades of zeal to improve oncologic adequacy and to decrease morbidity has led to the current scientific knowledge of retroperitoneal lymph node dissection templates Retroperitoneal lymph node dissection RPLND has potential for staging prognostication and therapeutic importance in the management of testicular malignancy RPLND has overcome limitations of current imaging which understage 30 of stage I disease and overstage 25–30 of stage II disease For lowvolume disease RPLND is curative in up to 90 cases without adjuvant therapy and has important role in postchemotherapy residual disease Risk of recurrence after RPLND is 1 and followup imaging can be limited thus avoiding their potential risk of radiation exposure RPLND reveals vital information of disease nature and guide adjuvant therapy Despite the long evolution period certain controversies still surround RPLND We aim to refine this challenging management in the following manuscript based on available evidence


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Vesical instillations of hyaluronic acid to reduce the acute vesical toxicity caused by high-dose brachytherapy do not affect the survival: a five-year follow-up study
  2. The expression and function of Frizzled-7 in human renal cell carcinoma
  3. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma
  4. Current status of anti-angiogenic agents in the treatment of ovarian carcinoma
  5. Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC)
  6. Dose–volume histogram parameters for predicting radiation pneumonitis using receiver operating characteristic curve
  7. Serum C-telopeptide levels predict the incidence of skeletal-related events in cancer patients with secondary bone metastases
  8. Breast metastases from a floor of the mouth carcinoma
  9. Clinical implications of KIT and PDGFRA genotyping in GIST
  10. Therapeutic vaccines for non-Hodgkin B-cell lymphoma
  11. Tissue fatty acid composition and secretory phospholipase-A2 activity in oral squamous cell carcinoma
  12. Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis
  13. Gastrointestinal stromal tumours at present: an approach to burning questions
  14. Consensus of the Spanish Society of Radiation Oncology (SEOR) Brachytherapy Group on brachytherapy in Breast Cancer
  15. Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer
  16. Selection of extreme phenotypes: the role of clinical observation in translational research
  17. Multiple bone lesions resembling a metastatic origin. An unexpected diagnosis
  18. VEGFR2 inhibition by RNA interference affects cell proliferation, migration, invasion, and response to radiation in Calu-1 cells
  19. The intra-tumor heterogeneity of cell signaling factors in breast cancer: p4E-BP1 and peIF4E are diffusely expressed and are real potential targets
  20. GAL3ST2 from mammary gland epithelial cells affects differentiation of 3T3-L1 preadipocytes
  21. Helicobacter pylori infection of the larynx may be an emerging risk factor for laryngeal squamous cell carcinoma
  22. Expression and prognostic role of c-Myb as a novel cell cycle protein in esophageal squamous cell carcinoma
  23. Role of axillary ultrasound, magnetic resonance imaging, and ultrasound-guided fine-needle aspiration biopsy in the preoperative triage of breast cancer patients
  24. Role of axillary ultrasound, magnetic resonance imaging, and ultrasound-guided fine-needle aspiration biopsy in the preoperative triage of breast cancer patients
  25. Pralatrexate, a new hope for aggressive T-cell lymphomas?

Search Result: